Clinical Trials Directory

Trials / Completed

CompletedNCT05346432

Effects of Lactobacillus Paracasei PS23 on Anti-fatigue

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Chi-Chang Huang · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise.

Detailed description

Studies have found that the intestinal flora of athletes is different from that of ordinary people, and short-chain fatty acids play a very important role. Previous animal experiments have found that supplementing with specific probiotics can slow down muscle loss in aging mice. In addition, clinical studies have found that supplementing with probiotics can improve sports performance by regulating the intestinal flora and related metabolites. Therefore, the purpose of this research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise. This study compares supplementary samples with placebo and adopts a double-blind study design.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPS23PS23 belongs to Lactobacillus paracasei group.Probiotic capsules contain 10 billion CFU (colony forming units) of PS23

Timeline

Start date
2022-05-01
Primary completion
2022-07-10
Completion
2022-07-10
First posted
2022-04-26
Last updated
2022-07-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05346432. Inclusion in this directory is not an endorsement.